Skip to content
Clinical Trials – home

Bacterial prostatitis Diagnostics

3 / 3 trials open to patients2 countries

In short

Bacterial prostatitis is a bacterial infection affecting the prostate gland that can appear suddenly or develop gradually over time. Recognizing when to seek medical care and understanding the diagnostic process are essential first steps toward proper treatment and relief from uncomfortable symptoms.

Key points

  • Bacterial prostatitis affects men in two distinct age groups—younger men aged 20 to 40 and older men over 70—with different risk factors in each population.
  • Acute bacterial prostatitis with fever, chills, and severe pain requires immediate medical attention as it can progress to life-threatening blood infection if ignored.
  • Diagnosis relies primarily on medical history, physical examination including digital rectal exam, and urine culture to identify the specific bacteria causing infection.
  • The two-glass urine test (pre- and post-prostate massage) offers a simpler alternative to the traditional four-glass test while still providing accurate diagnostic information.
  • Vigorous prostate massage should be avoided in acute cases because it risks spreading bacteria into the bloodstream and causing dangerous complications.
  • Elevated PSA levels during active prostatitis don't necessarily indicate cancer—inflammation itself raises PSA, which typically normalizes after successful treatment.
  • Negative urine cultures despite symptoms often point toward chronic pelvic pain syndrome rather than bacterial infection, requiring different treatment approaches.
  • Clinical trials require rigorous diagnostic documentation including standardized symptom questionnaires, bacterial culture confirmation, and sometimes imaging studies before enrollment.

Introduction: Who Should Seek Diagnostic Testing

Men experiencing pain in the pelvic area, problems with urination, or flu-like symptoms should consider seeking medical evaluation for possible bacterial prostatitis. This condition primarily affects men in two age groups: those between 20 and 40 years old, and those over 70 years of age. Understanding when to see a healthcare provider can make a significant difference in preventing complications and starting treatment early.

You should seek medical attention if you notice persistent pain when urinating, frequent urgent needs to urinate especially at night, or difficulty starting or maintaining a urine stream. Pain in the lower abdomen, lower back, genitals, or the area between the scrotum and rectum—known as the perineum—are also warning signs. Some men may notice blood in their urine or semen, or experience pain during ejaculation or sexual intercourse.

Certain groups of men have higher risk and should be especially alert to symptoms. Men who have recently undergone procedures involving the urinary tract—such as catheterization, cystoscopy, or prostate biopsy—are at increased risk. Those with an enlarged prostate, urinary tract infections, sexually transmitted infections, or weakened immune systems should also watch for symptoms carefully.

Early diagnosis matters because bacterial prostatitis can lead to complications if ignored. In chronic cases, recurring infections may develop, making treatment more difficult and lengthy. Some men experience ongoing pain and discomfort that affects their quality of life and sexual function. In acute cases, the infection can spread to the bloodstream, causing a serious condition called sepsis, which is life-threatening.

Classic Diagnostic Methods

Diagnosing bacterial prostatitis primarily relies on a careful evaluation of symptoms, physical examination, and laboratory tests. Your healthcare provider will begin by asking detailed questions about your symptoms, including when they started, how severe they are, and whether you've had similar problems before. Information about recent medical procedures, sexual activity, and any history of urinary or prostate problems helps doctors understand your individual situation.

Physical Examination

The physical examination includes checking your abdomen, genitals, and performing a digital rectal exam. During this exam, the healthcare provider gently inserts a gloved, lubricated finger into the rectum to feel the prostate gland. This examination helps identify whether the prostate is enlarged, swollen, tender, or feels soft or boggy—all signs that may indicate infection or inflammation.

In cases of suspected acute bacterial prostatitis, the digital rectal exam must be performed very gently or may be avoided altogether. The reason is that vigorous examination or prostate massage could potentially spread bacteria into the bloodstream, causing serious complications. Healthcare providers are trained to recognize when this caution is necessary based on the severity of symptoms.

Urine Testing

Urine samples are essential for diagnosing bacterial prostatitis. Your doctor will request a urinalysis, which examines your urine for signs of infection such as white blood cells, red blood cells, or bacteria. This test can reveal whether you have a urinary tract infection and provides clues about inflammation in the prostate.

More importantly, urine culture tests identify the specific bacteria causing the infection. A midstream clean-catch urine sample is collected, meaning you start urinating into the toilet, then collect urine in a sterile container, and finish urinating into the toilet again. This technique reduces contamination from bacteria normally present on the skin. The sample is sent to a laboratory where it's examined to identify which bacteria are present and which antibiotics will work best against them.

Some doctors use specialized testing methods to pinpoint whether the infection is specifically in the prostate. The traditional method is called the four-glass test, where urine samples are collected at different stages, and prostatic fluid is obtained through prostate massage. However, many clinics now use a simpler two-glass test, also called the pre-massage and post-massage test. This involves collecting urine samples before and after gentle prostate massage, which is easier for patients and still provides useful diagnostic information.

Blood Tests

Blood tests may be ordered depending on how sick you appear and whether certain complications are suspected. If you have a fever higher than 101.1°F (38.4°C), blood cultures might be taken to check whether bacteria have entered your bloodstream. Blood tests can also show signs of widespread infection or inflammation through elevated white blood cell counts.

Your doctor may check your prostate-specific antigen or PSA level, a protein produced by the prostate. However, this test has limitations when diagnosing prostatitis because infections and inflammation can temporarily raise PSA levels even without cancer being present. For this reason, PSA testing is not routinely recommended during active prostatitis and may be delayed until after the infection has been treated.

Imaging Tests

In most cases of bacterial prostatitis, imaging tests like X-rays, ultrasounds, or CT scans are not needed for diagnosis. However, if you have a high fever that lasts longer than 36 hours despite antibiotic treatment, your doctor may order imaging to check for complications such as a prostatic abscess—a collection of pus within the prostate gland. Ultrasound or CT scans can reveal these abscesses, which may require drainage.

Imaging might also be used if there's concern about other problems affecting the urinary tract, such as kidney stones, bladder abnormalities, or structural issues that could be contributing to recurrent infections.

Distinguishing Bacterial Prostatitis from Other Conditions

Healthcare providers must distinguish bacterial prostatitis from other conditions that cause similar symptoms. Chronic pelvic pain syndrome, the most common type of prostatitis, causes pain and urinary symptoms but without consistent evidence of bacterial infection. Unlike bacterial prostatitis, urine cultures in chronic pelvic pain syndrome are typically negative or show inconsistent results.

Other conditions that may mimic bacterial prostatitis include enlarged prostate (benign prostatic hyperplasia), urinary tract infections not involving the prostate, bladder pain syndrome, urethral strictures, and even prostate or bladder cancer. Each condition requires different treatment approaches, which is why accurate diagnosis through careful testing is crucial.

The key difference lies in finding consistent bacterial growth in cultures and confirming that the infection originates in the prostate rather than elsewhere in the urinary system. In chronic bacterial prostatitis specifically, doctors look for recurrent urinary tract infections where the same bacteria appear repeatedly in cultures, suggesting the prostate is serving as a reservoir for infection.

Diagnostics for Clinical Trial Qualification

Clinical trials studying bacterial prostatitis often use standardized diagnostic criteria to ensure participants truly have the condition being investigated. While general clinical practice may vary somewhat between providers, research studies require consistent, reproducible methods to accurately evaluate new treatments.

Research protocols typically follow the classification system developed by the National Institutes of Health, which divides prostatitis into four categories. For bacterial prostatitis studies, participants must demonstrate clear evidence of bacterial infection through positive urine cultures showing the same organism repeatedly in chronic cases, or acute symptoms with confirmed bacterial presence in acute cases.

Clinical trials often require specific documentation before enrolling participants. This may include detailed symptom questionnaires measuring the severity of pain, urinary difficulties, and impact on quality of life. The NIH Chronic Prostatitis Symptom Index is one standardized tool that rates symptoms on numerical scales, allowing researchers to track improvements objectively during treatment studies.

Laboratory confirmation is essential for trial enrollment. Participants typically must provide urine culture results identifying specific bacteria and demonstrating bacterial counts above certain thresholds. Some studies require the four-glass localization test or two-glass test to confirm the infection resides in the prostate rather than just the urethra or bladder.

Trials may also require imaging studies like ultrasound or MRI to rule out other conditions or complications. Digital rectal examination findings must be documented, noting the size, consistency, and tenderness of the prostate. These baseline measurements help researchers track whether experimental treatments reduce prostate inflammation over time.

Blood tests including complete blood counts, kidney function tests, and PSA levels may be required at enrollment and at regular intervals during the trial. These tests help monitor for side effects from experimental treatments and ensure participant safety throughout the study period.

Studies investigating chronic bacterial prostatitis often require documentation that participants have experienced recurrent infections over a specified time period—typically three months or longer. They must show that symptoms return when antibiotic treatment stops, confirming the chronic nature of the infection rather than a single acute episode that was incompletely treated.

Some research protocols screen for antibiotic resistance patterns in bacteria causing the infection. With growing concerns about antibiotic-resistant bacteria, trials testing new antibiotics or treatment combinations may specifically seek participants whose infections don't respond to standard medications. Culture and sensitivity testing identifies which antibiotics the bacteria are resistant to, helping match patients with appropriate experimental treatments.

Prognosis and Survival Rate

Prognosis

The outlook for men with bacterial prostatitis depends largely on whether the infection is acute or chronic. Acute bacterial prostatitis generally responds well to antibiotic treatment when caught early. Most men recover completely with appropriate antibiotics taken for two to six weeks, though some may need additional treatment if symptoms persist or return.

Chronic bacterial prostatitis presents more challenges. Approximately 5% of men who experience acute bacterial prostatitis may develop the chronic form, where infections recur or persist despite treatment. These men typically need longer courses of antibiotics lasting at least two to six weeks, and some may require treatment for up to 12 weeks. Even after completing treatment, infections can return, requiring repeated antibiotic courses.

Several factors affect prognosis. Men with underlying conditions like enlarged prostate, urinary tract blockages, or weakened immune systems may experience more difficulty clearing infections completely. Those who have undergone procedures involving the urinary tract or prostate may face higher rates of treatment failure or recurrence. Age also plays a role, with older men sometimes experiencing more complicated infections.

Long-term complications from bacterial prostatitis are relatively uncommon when properly treated but can include recurring urinary tract infections, chronic pelvic pain, sexual dysfunction including painful ejaculation and erectile problems, and in rare cases, the development of prostatic abscesses. These complications typically affect men whose infections were not treated promptly or who have chronic bacterial prostatitis that proves difficult to eradicate.

The good news is that bacterial prostatitis, unlike the more common chronic pelvic pain syndrome, has identifiable causes and established treatments. With proper antibiotic therapy guided by culture results, most men experience significant improvement. However, patience is often required, as complete resolution of symptoms may take several weeks even after bacteria are cleared from the prostate.

Survival rate

Bacterial prostatitis itself is not a life-threatening condition in the vast majority of cases, and survival rates approach 100% with appropriate treatment. However, acute bacterial prostatitis can occasionally lead to serious complications if left untreated. The most concerning is sepsis, a life-threatening response to infection where bacteria enter the bloodstream and spread throughout the body.

Mortality from bacterial prostatitis is extremely rare and typically only occurs in cases where acute infection progresses to sepsis in vulnerable patients—such as those who are elderly, have significantly weakened immune systems, or delay seeking medical care. When acute bacterial prostatitis is recognized and treated promptly with antibiotics, these serious complications are easily prevented.

Chronic bacterial prostatitis does not directly threaten life expectancy. While it can significantly affect quality of life through recurring infections, pain, and urinary problems, it does not reduce lifespan when managed appropriately. The main impact is on daily comfort and function rather than mortality risk.

Did you know?

  1. More than 2 million men visit healthcare providers every year for prostatitis symptoms, and up to 50% of all men will experience symptoms at some point in their lives, making it remarkably common.[1]
  2. Despite bacteria being found in urine cultures, chronic bacterial prostatitis accounts for less than 10% of all prostatitis cases—the overwhelming majority of prostatitis is actually not caused by bacterial infection at all.[12]
  3. Escherichia coli, the same bacteria commonly found in the digestive tract, causes anywhere from 50% to 90% of bacterial prostatitis cases, making this intestinal bacterium the leading culprit behind prostate infections.[4]

Questions people often ask

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Clinical trials for Bacterial prostatitis

Recruiting trials first

See all 3 trials →
Quick filters

3 clinical trials in this condition

Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Ciprofloxacin
  • Sponsor:UZ Brussel
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Cefixime
  • Sponsor:Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca

Bacterial prostatitis+1

Not yet recruiting
Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Fosfomycin
  • Sponsor:Fundacio Assistencial De Mutua De Terrassa Fpc
See all 3 trials →filters applied: condition = Bacterial prostatitis

Related conditions in the same therapeutic area

Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).